相似文献
1
Advance at a glance: contributions to cardio-oncology.
Eur Heart J Open. 2025 Jun 20;5(3):oeaf075. doi: 10.1093/ehjopen/oeaf075. eCollection 2025 May.
2
Core outcome set for cardio-oncology: development of a set of outcomes for the cardiovascular assessment and monitoring of cancer patients and survivors.
Eur Heart J Qual Care Clin Outcomes. 2025 Jun 23;11(4):367-377. doi: 10.1093/ehjqcco/qcae038.
3
Cardio-Oncology and Multi-Imaging Modalities.
J Clin Med. 2025 Jun 18;14(12):4353. doi: 10.3390/jcm14124353.
4
Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review & bayesian network meta-analysis.
Eur J Cancer. 2022 Jul;169:82-92. doi: 10.1016/j.ejca.2022.03.024. Epub 2022 May 4.
5
Normobaric hypoxic conditioning to maximize weight loss and ameliorate cardio-metabolic health in obese populations: a systematic review.
Am J Physiol Regul Integr Comp Physiol. 2017 Sep 1;313(3):R251-R264. doi: 10.1152/ajpregu.00160.2017. Epub 2017 Jul 5.
6
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study.
Stroke Vasc Neurol. 2024 Oct 2. doi: 10.1136/svn-2023-003029.
7
Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
Cochrane Database Syst Rev. 2022 Jul 26;7(7):CD011964. doi: 10.1002/14651858.CD011964.pub2.
8
Digital Therapeutics-Based Cardio-Oncology Rehabilitation for Lung Cancer Survivors: Randomized Controlled Trial.
JMIR Mhealth Uhealth. 2025 Feb 25;13:e60115. doi: 10.2196/60115.
9
Advancing Cardio-Oncology in Asia.
Korean Circ J. 2023 Feb;53(2):69-91. doi: 10.4070/kcj.2022.0255.
10
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Cochrane Database Syst Rev. 2013 Sep 11(9):CD009160. doi: 10.1002/14651858.CD009160.pub2.
本文引用的文献
1
Cardioprotective drugs and heart failure/cardiomyopathy incidence in chemotherapy-treated cancer survivors of breast cancer and non-Hodgkin lymphoma: a retrospective cohort study in England.
Eur Heart J Open. 2025 Apr 25;5(3):oeaf039. doi: 10.1093/ehjopen/oeaf039. eCollection 2025 May.
2
Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-20.
Eur Heart J Open. 2025 Apr 23;5(3):oeaf043. doi: 10.1093/ehjopen/oeaf043. eCollection 2025 May.
3
Ischaemic and bleeding risk after ST-elevation myocardial infarction in patients with active cancer: a nationwide study.
Eur Heart J Open. 2025 Feb 12;5(2):oeaf012. doi: 10.1093/ehjopen/oeaf012. eCollection 2025 Mar.
4
Trends and disparities in cardiovascular disease-related mortality among adults with myeloproliferative neoplasms in USA.
Eur Heart J Open. 2024 Dec 18;5(1):oeae101. doi: 10.1093/ehjopen/oeae101. eCollection 2025 Jan.
5
Global burden of cardiovascular diseases: projections from 2025 to 2050.
Eur J Prev Cardiol. 2024 Sep 13. doi: 10.1093/eurjpc/zwae281.
6
Performance of CHADS-VASc and HAS-BLED in predicting stroke and bleeding in atrial fibrillation and cancer.
Eur Heart J Open. 2024 Jun 26;4(4):oeae053. doi: 10.1093/ehjopen/oeae053. eCollection 2024 Jul.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
Heart Failure Readmission in Patients With ST-Segment Elevation Myocardial Infarction and Active Cancer.
JACC CardioOncol. 2024 Jan 9;6(1):117-129. doi: 10.1016/j.jaccao.2023.10.011. eCollection 2024 Feb.
9
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis.
Heart Fail Rev. 2023 Nov;28(6):1405-1415. doi: 10.1007/s10741-023-10328-z. Epub 2023 Jul 7.
10
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study.
Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):806-817. doi: 10.1093/ehjqcco/qcad012.
Zotero 插件